Delivery Order SPE2DB25D3504-SPE2DB25FVVRR
- Not listed
- The Defense Logistics Agency awarded a $2,376.88 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of 36,000 unit capsules of Creon 100s, a pancreatic enzyme replacement therapy. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of 36,000 unit capsules of Creon DR 100s with a ceiling value of $58,274.04. This firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation and represents a continuation of the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for 36,000 units of Creon DR 100s capsules with a ceiling value of $5,071.22. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 24, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of 36,000 units of Creon DR capsules (100s formulation) with a ceiling value of $7,070.70. This firm fixed-price delivery order is not set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $6,901.55 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply support to federal medical systems. The delivery will be performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Creon DR 36,000 unit capsules in quantities of 100 units. This non-set-aside, firm fixed-price delivery order has a ceiling value of $6,733.40 and is scheduled for ultimate completion by August 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $8,144.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules, with an ultimate completion date of September 4, 2025. This non-set-aside contract was awarded competitively and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical support vehicle that runs through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Creon DR 24,000 unit capsules in quantities of 100s, with a ceiling value of $1,718.56. This is a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competitively awarded among qualified...
- The Defense Logistics Agency awarded a $7,093.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for 36,000 units of Creon DR 100-strength capsules, with an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract represents a single delivery order for pharmaceutical supplies to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Creon DR 36,000 unit capsules in 100-count packages, with a contract value of $3,339.59 and completion date of August 22, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award supporting federal pharmaceutical procurement needs. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVVRRDelivery Order
The Defense Logistics Agency awarded a $5,474.32 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of 36,000 units of Creon DR 100s capsules, with a completion date of July 25, 2025. This non-set-aside contract is structured as a firm fixed-price delivery order and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the contractor's critical role in supporting federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor agreement enables the company to supply a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The contractor's consistent award of non-set-aside, competitively awarded contracts demonstrates its capability to meet federal procurement requirements and serve multiple government healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 7/24/25 |